Jagannath Sherigar
Overview
Explore the profile of Jagannath Sherigar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guss D, Sherigar J, Mohanty S
Gastroenterol Nurs
. 2020 Jan;
43(1):22-27.
PMID: 31913958
Nurses have been at the forefront of the care of patients with hepatitis C since hepatitis C virus was identified in 1989. Treatments of patients with hepatitis C have evolved...
2.
Guss D, Sherigar J, Mohanty S
Gastroenterology Res
. 2018 Oct;
11(5):333-339.
PMID: 30344803
Background: Cirrhosis of the liver is often not recognized until late in the disease state, when patients decompensate or develop hepatocellular carcinoma (HCC). This inquiry considered factors associated with undiagnosed...
3.
Gayam V, Mandal A, Khalid M, Mukhtar O, Gill A, Garlapati P, et al.
Gastroenterology Res
. 2018 Aug;
11(4):309-316.
PMID: 30116431
Background: Low serum vitamin D levels in chronic hepatitis C (CHC) is associated with advanced liver fibrosis; and there remains an imprecise relationship with the treatment response based on the...
4.
Gayam V, Tiongson B, Khalid M, Mandal A, Mukhtar O, Gill A, et al.
Eur J Gastroenterol Hepatol
. 2018 Aug;
30(10):1200-1207.
PMID: 30096090
Background: Direct-acting antiviral (DAA) drugs have been highly effective in the treatment of chronic hepatitis C (HCV) infection. Limited data exist comparing the safety, tolerability, and efficacy of DAAs in...
5.
Gayam V, Hossain M, Khalid M, Chakaraborty S, Mukhtar O, Dahal S, et al.
Gut Liver
. 2018 Jun;
12(6):694-703.
PMID: 29938459
Background/aims: Limited data exist comparing the safety and efficacy of direct-acting antivirals (DAAs) in hepatitis C virus (HCV) monoinfected and HCV/human immunodeficiency virus (HIV) coinfected patients in the real-world clinic...
6.
Gayam V, Khalid M, Mandal A, Hussain M, Mukhtar O, Gill A, et al.
Gastroenterology Res
. 2018 May;
11(2):130-137.
PMID: 29707080
Background: Limited data exists comparing the safety, tolerability, and efficacy of direct-acting antivirals (DAAs) in patients with chronic hepatitis C genotype 4 (HCV GT-4) in the community practice setting. We...
7.
Guss D, Sherigar J, Rosen P, Mohanty S
J Gen Intern Med
. 2018 Jan;
33(4):551-557.
PMID: 29352420
Hepatitis C virus (HCV) infection is a significant health problem worldwide, and is the leading cause of cirrhosis, hepatocellular carcinoma, and liver transplantation in the United States. The management of...
8.
Swe T, Baqui A, Thein Naing A, Baqui T, Sherigar J, Mansour M
J Community Hosp Intern Med Perspect
. 2016 Dec;
6(6):33114.
PMID: 27987283
Schistosomiasis is an important parasitic disease with various clinical presentations caused by trematode blood flukes. It can present with asymptomatic, chronic colonic ulcerations, strictures, or inflammatory mass causing bowel obstruction....
9.
Sherigar J, Kumar S, Wali J
Ulster Med J
. 2007 May;
76(2):116.
PMID: 17476831
No abstract available.